GASTROENTEROLOGY,  INFECTIOUS DISEASES,  TRAVEL MEDICINE

Strongyloidiasis

  • Strongyloidiasis is primarily an infection of the small bowel by the filarial worm Strongyloides stercoralis 
  • it is endemic in the tropics and subtropics but also seen in countries with temperate climates, people who have lived or travelled to these areas are also at risk
  • infection can be either acute or chronic in nature 
  • Transmission of the infection may occur through:
    • direct penetration of human skin by infective larvae when in contact with soil e.g. – walking barefoot
    • oro-anal contact – seen in homosexual men
    • solid organ transplants – there have been reports of transmission of the infection derived from the donor organ 
    • faecal-oral route – may be possible when larvae contaminated water is used to wash vegetables in endemic areas 
  • Most infections are asymptomatic however immunosuppressed individuals may suffer gross infection.
  • Most infections are either mild or asymptomatic.
    • In these patients an increase in peripheral blood eosinophil count is the only sign of infection 
  • life-cycle
    • Faecal soil contamination with S stercoralis larvae are most likely to be seen in rurual areas with poor sanitation.
    • filariform larvae in the soil penetrate the skin when the host walks barefoot on contaminated soil
    • parasitic cycle
      • larve enters venous circulation and migrate to the lungs. 
      • They are coughed up and swallowed.
      • the larvae in the small intestine develops into adult female. 
      • The reproduce asexually and release eggs into the digestive system
      • hatched eggs release non-infectious rhabditiform larvae which is excreted in stools and enter the soil
    • free living cycle
      • these free-living rhabditiform larvae may mature into male and female adult worms, which reproduce sexually or transform directly into filariform larvae 
      • S stercoralis parasite has the ability to reinfect the host through the wall of gastrointestinal system – known as autoinfection:
      • this is caused by rhabditiform larvae in the faeces which transforms into infectious filariform larvae inside the gastrointestinal system. 
      • These filariform larvae  penetrates the gut wall and enter the circulation and migrate to the lungs to begin the cycle again 

Symptoms

ground itch
  • characteristic cutaneous reaction following acute larvae invasion of the skin
  • most commonly affects the foot
  • may cause serpiginous or urticarial tracts with severe pruritus lasting for several days

larva currens (literally “running larvae”)    
  • intensely itchy red tracts seen in the perianal area and upper thighs due to rapid speed of intradermal migration (progressing at around 5-15 cm per hour) of the parasite  in chronic infection
  • pathognomonic for strongyloidiasis
pulmonary manifestations
  • dry cough or wheeze
  • Loeffler’s-like syndrome
  • rare
  • characterised by fever, dyspnoea, wheeze, pulmonary infiltrates on chest radiographs, and accompanying blood eosinophilia
gastrointestinal manifestations
  • diarrhoea, anorexia, and vomiting
  • epigastric pain worsened by eating
Disseminated strongyloidiasis seen in immunosuppressed patients may present with
  • abdominal pain and distension
  • shock
  • pulmonary and neurologic complications
  • septicemia 

should be investigated for strongyloidiasis:

  • travelers or people who migrate from an endemic area and develop the following within 3-4 weeks of travel:
    • persistent unexplained eosinophilia
    • gastrointestinal symptoms: nausea, vomiting, abdominal pain, bloating
    • pulmonary symptoms: fever, wheeze, persistent cough
    • cutaneous symptoms: larva currens, hives, or pustules

Investigations

  • three stool samples for microscopy – collected on separate days
    • although the test has low sensitivity for detecting S stercoralis (around 50%) it is considered to be the gold standard for diagnosis
    • larvae usually appear in stools 3-4 weeks after dermal penetration.
  • blood test for S stercoralis serology
    • detects IgG to a filariform larval antigen

treatment

  • ivermectin
    • 2×200 μg/kg doses of oral ivermectin is given two weeks apart
  • Albendazole
  • Repeat serological testing is used as an indicator of treatment efficacy
    • a decrease in the antibody titre  at 6-12 months after treatment is considered to be an indicator of  eradication of the parasiTE
    • a significant decrease in blood eosinophil count  can also be used as an effective tool 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.